| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evofem Biosciences, Inc. | Chief Financial Officer | Common Stock | 24.1K | $927 | $0.04 | Dec 31, 2022 | Direct |
| Lite Strategy, Inc. | CEO, CFO and Secretary, Director | Stock Option (Right to Buy) | 180K | Nov 14, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LITS | Lite Strategy, Inc. | Nov 14, 2025 | 1 | $0 | 4/A | Nov 20, 2025 | CEO, CFO and Secretary, Director |
| MEIP | MEI Pharma, Inc. | Jul 15, 2025 | 1 | $0 | 4 | Jul 17, 2025 | Secretary, Acting CEO & CFO |
| MEIP | MEI Pharma, Inc. | Jun 12, 2023 | 0 | $0 | 3 | Aug 1, 2023 | CFO and Corporate Secretary |
| EVFM | Evofem Biosciences, Inc. | Dec 31, 2022 | 1 | $0 | 5 | May 8, 2023 | Chief Financial Officer |
| EVFM | Evofem Biosciences, Inc. | Feb 18, 2022 | 2 | $0 | 4 | Feb 23, 2022 | Chief Financial Officer |
| EVFM | Evofem Biosciences, Inc. | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | Chief Financial Officer |
| EVFM | Evofem Biosciences, Inc. | Dec 20, 2021 | 1 | $15K | 4 | Dec 20, 2021 | Chief Financial Officer |
| EVFM | Evofem Biosciences, Inc. | Jun 10, 2021 | 1 | $25.2K | 4 | Jun 10, 2021 | Chief Financial Officer |
| EVFM | Evofem Biosciences, Inc. | May 20, 2021 | 1 | -$36.4K | 4 | May 21, 2021 | Chief Financial Officer |